Oticara

Focus: Oticara is a biotechnology company focused on developing treatments for eosinophilic chronic sinusitis, a specialized inflammatory condition affecting the nasal sinuses. The company is early-stage with a focused pipeline targeting an underserved patient population.

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Oticara

AI assessmentNot Hiring

No open roles listed right now. Follow Oticara to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Betamethasone Dipropionate Nasal Cream 0.0644%

Chronic Rhinosinusitis (Diagnosis)

Phase 1/2

Clinical Trials (1)

NCT05220293Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream

Phase 1/2

Help build intelligence for Oticara

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on a specialized, underexplored indication (eosinophilic chronic sinusitis) with limited competitive treatment options
Early-stage biotech allows direct impact on drug development strategy and clinical program design
Located in Austin, TX, a growing biotech hub with lower cost of living than coastal pharma centers

Watch Out For

Pre-revenue stage with no disclosed funding or financial data raises sustainability and runway concerns
Zero current job openings and minimal company information (founding date, employee count unknown) suggest very early or dormant stage
Only 2 early-phase trials (Phase 1/2 and Phase 2) with no Phase 3 programs or clinical catalysts near-term

Generated by Claude from Oticara's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Betamethasone Dipropionate Nasal Cream 0.0644%

Chronic Rhinosinusitis (Diagnosis)

Phase 2

Clinical Trials (1)

NCT05882903The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo